Journal List > J Korean Orthop Assoc > v.53(5) > 1106382

Oh and Rhee: Non-Operative Management of Musculoskeletal Diseases and Regenerative Medicine

Abstract

Recently, due to the unsatisfactory outcomes of several orthopedic surgical procedures, non-operative management of musculoskeletal diseases, including regenerative medicine, is becoming more attractive to orthopedic surgeons. Regarding the healing of musculoskeletal tissues, such as bone, cartilage and tendons, regenerative medicine aims to replace or promote tissue regeneration. Among them, therapy using stem cells, prolotherapy, platelet-rich plasma, and extracorporeal shockwave therapy are taking center stage. Numerous animal and clinical studies have been published and the number has increased exponentially in recent years. On the other hand, because regenerative medicine in the orthopedic field is still in the early stages, no definite methods for the procedures have been made and there is some controversy regarding their application to musculoskeletal disease. Therefore, more high quality studies including randomized studies should be performed to establish standards and evaluate their value in the orthopedic field.

Notes

CONFLICTS OF INTEREST The authors have nothing to disclose.

References

1. Corsi KA, Schwarz EM, Mooney DJ, Huard J. Regenerative medicine in orthopaedic surgery. J Orthop Res. 2007; 25:1261–1268.
crossref
2. Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med. 2008; 3:1–5.
crossref
3. Markets and Markets. Global regenerative medicine market analysis & forecast to 2021. Pune (India): Markets and Markets;2016.
4. Biotech Policy Research Center. BioINdustry No. 110. Regenerative medicines market-Global forecast to 2021 [Internet]. Daejeon: Biotech Policy Research Center;2016. 11. 30. cited 2017 Nov 23. Available from: http://www.bioin.or.kr/board.do?num=265610&cmd=view&bid=watch.
5. Notarnicola A, Moretti B. The biological effects of extracorporeal shock wave therapy (eswt) on tendon tissue. Muscles Ligaments Tendons J. 2012; 2:33–37.
6. Frank C, Amiel D, Woo SL, Akeson W. Normal ligament properties and ligament healing. Clin Orthop Relat Res. 1985; 196:15–25.
crossref
7. Biedert RM, Stauffer E, Friederich NF. Occurrence of free nerve endings in the soft tissue of the knee joint. A histologic investigation. Am J Sports Med. 1992; 20:430–433.
8. Müller SA, Todorov A, Heisterbach PE, Martin I, Majewski M. Tendon healing: an overview of physiology, biology, and pathology of tendon healing and systematic review of state of the art in tendon bioengineering. Knee Surg Sports Traumatol Arthrosc. 2015; 23:2097–2105.
crossref
9. Oliva F, Via AG, Maffulli N. Role of growth factors in rotator cuff healing. Sports Med Arthrosc Rev. 2011; 19:218–226.
crossref
10. Würgler-Hauri CC, Dourte LM, Baradet TC, Williams GR, Soslowsky LJ. Temporal expression of 8 growth factors in tendon-to-bone healing in a rat supraspinatus model. J Shoulder Elbow Surg. 2007; 16:S198–S203.
crossref
11. Lui PP. Stem cell technology for tendon regeneration: current status, challenges, and future research directions. Stem Cells Cloning. 2015; 8:163–174.
crossref
12. Man GS, Mologhianu G. Osteoarthritis pathogenesis - a complex process that involves the entire joint. J Med Life. 2014; 7:37–41.
13. Hashimoto S, Ochs RL, Komiya S, Lotz M. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 1998; 41:1632–1638.
crossref
14. Schmitt A, van Arthritis Rheum M, Imhoff AB, Buchmann S. Application of stem cells in orthopedics. Stem Cells Int. 2012; 2012:394962.
crossref
15. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126:663–676.
crossref
16. Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev. 2010; 62:1156–1166.
crossref
17. Hackett GS. Prolotherapy in whiplash and low back pain. Postgrad Med. 1960; 27:214–219.
crossref
18. Ongley MJ, Klein RG, Dorman TA, Eek BC, Hubert LJ. A new approach to the treatment of chronic low back pain. Lancet. 1987; 2:143–146.
crossref
19. Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clin Med Insights Arthritis Musculoskelet Disord. 2016; 9:139–159.
crossref
20. Reeves KD, Hassanein KM. Long-term effects of dextrose prolotherapy for anterior cruciate ligament laxity. Altern Ther Health Med. 2003; 9:58–62.
21. Zhou SF, Estrera AL, Miller CC 3rd, et al. Analysis of autologous platelet-rich plasma during ascending and transverse aortic arch surgery. Ann Thorac Surg. 2013; 95:1525–1530.
crossref
22. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004; 62:489–496.
crossref
23. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004; 91:4–15.
crossref
24. Choi BH, Zhu SJ, Kim BY, Huh JY, Lee SH, Jung JH. Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg. 2005; 34:420–424.
crossref
25. Oh JH, Kim W, Park KU, Roh YH. Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations. Am J Sports Med. 2015; 43:3062–3070.
crossref
26. Roh YH, Kim W, Park KU, Oh JH. Cytokine-release kinetics of platelet-rich plasma according to various activation protocols. Bone Joint Res. 2016; 5:37–45.
crossref
27. Wang CJ. Extracorporeal shockwave therapy in musculoskeletal disorders. J Orthop Surg Res. 2012; 7:11.
crossref
28. Pettrone FA, McCall BR. Extracorporeal shock wave therapy without local anesthesia for chronic lateral epicondylitis. J Bone Joint Surg Am. 2005; 87:1297–1304.
crossref
29. Schmitz C, Császár NB, Milz S, et al. Efficacy and safety of extracorporeal shock wave therapy for orthopedic conditions: a systematic review on studies listed in the PEDro database. Br Med Bull. 2015; 116:115–138.
crossref
30. Oh JH, Yoon JP, Oh CH, Jo KH, Gong HS. Dose-related effect of extracorporeal shock wave therapy for lateral epicondylitis: prospective randomized double blind comparative study. J Korean Shoulder Elbow Soc. 2009; 12:21–26.
Rompe JD., Kirkpatrick CJ., Küllmer K., Schwitalle M., Krischek O. Dose-related effects of shock waves on rabbit tendo Achillis. A sonographic and histological study. J Bone Joint Surg Br. 1998. 80:546–552.
32. Sanderson LM, Bryant A. Effectiveness and safety of prolotherapy injections for management of lower limb tendinopathy and fasciopathy: a systematic review. J Foot Ankle Res. 2015; 8:57.
crossref
TOOLS
ORCID iDs

Sung-Min Rhee
https://orcid.org/0000-0002-7087-4219

Similar articles